Archive issues
Author:
Title:
Keywords:
Newsletter
Enter your email:
Publications About the journal Submit manuscript CEJU Publication System Subscription Contact

2010 Vol. 63 No. 4

Review Paper2010-09-02
10.5173/ceju.2010.04.art1
Biopsy of the prostate - the urge to search for a new standard
Artur A. Antoniewicz, Łukasz Zapała, Andrzej Borówka, Theo M. de Reijke
Although the worldwide urological community generally accepts the existing protocol of TRUS-guided random prostate biopsy, there is strong evidence that sextant, extended and saturation protocols are not sufficiently accurate (ranges from 28-78%). Moreover, the number of repeated biopsies remains extremely high (33%) as a consequence of using an imperfect diagnostic tool. An overview of current literature concerning common practice in prostatic biopsies has revealed a discrepancy in indications, technique, number of cores collected, and pathological examination standards

FULL TEXT

Original Basic Research And Clinical Articles2010-09-04
10.5173/ceju.2010.04.art2
CHEK2 gene mutations, CYPB gene 355T/T polymorphism and HPV infection, approached as urinary bladder cancer predisposing factors
Monika Banaszkiewicz, Maria Constantinou, Michał Pietrusiński, Adam Jędrzejczyk, Marek Rożniecki, Piotr Marks, Bogdan Kałużewski
CHEK2 and CYP1B1 are among the genes, the mutations of which may increase the risk of cancer incidence. The multi-organ predisposition of these genes to induce neoplasm development has been reported.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Original Basic Research And Clinical Articles2010-08-18
10.5173/ceju.2010.04.art3
Isoflavones augment the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on prostate cancer cells
Ewelina Szliszka, Joanna Bronikowska, Zenon P. Czuba, Wojciech Krol
Isoflavones are the subclass of flavonoids with chemopreventive and anticancer activities. Isoflavones induce cytotoxicity and apoptosis in prostate cancer cells. TRAIL plays an important role in immune surveillance and the defense mechanism against tumor cells. However, not all tumor cells are sensitive to TRAIL. TRAIL-resistant cancer cells can be sensitized to TRAIL-induced apoptosis by flavonoids.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Case Report2010-08-17
10.5173/ceju.2010.04.art4
Primary Vaginal Stone in a Disabled Child.
Wiesław Urbanowicz, Sabina Szymik-Kantorowicz, Janusz Sulisławski, Michał Wolnicki
Authors report a case of a large primary vaginal calculus in a eleven year old girl. Vaginal stones are relatively rare. Various causes can lead to vaginal stone formation. In our case , the calculi was due to minor vaginal outlet obstruction and permanently in bed-ridden with urinary incontinence and chronic urinary infection. In our patient x-ray film using frontal and lateral views during cystography permitted to establish the right diagnosis. The treatment was surgical incision of vaginal introitus and extraction of calculi.

FULL TEXT

Case Report2010-09-14
10.5173/ceju.2010.04.art5
Rare renal tumors - Bellini duct carcinoma
Andrzej Kierstan, Marek Sosnowski, Radosław Minias, Zbigniew Jabłonowski
Bellini duct carcinoma is a rare type of renal tumor characterized by high malignancy.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Case Report2010-08-13
10.5173/ceju.2010.04.art6
Paraganglioma Displacing IVC: A Surgical Challenge
Kristell Acosta, Akin Tekin, Daniel Rosenberg, Mohan Arianayagam, Murugesan Manoharan
Paragangliomas are catecholamine-secreting tumors that originate from chromaffin cells in the sympathetic ganglia. Commonly presenting with excess cathecholamine symptoms, these tumors are usually treated with surgical excision. We present a case of an abdominal paraganglioma located between the aorta and the inferior vena cava and discuss the challenges associated with the resection of this tumor in such a complex location.

FULL TEXT

Case Report2010-08-31
10.5173/ceju.2010.04.art7
Case report: Laparoscopic radical nephrectomy in the presence of a duplicated inferior vena cava
Christopher S. Gomez, Mohan Arianayagam, Victor J. Casillas, Gaetano Ciancio
Inferior vena cava (IVC) anomalies are often asymptomatic but have considerable clinical implications during retroperitoneal surgery. While laparoscopic radical nephrectomy (LRN) has become standard of care, retroperitoneal vascular injury remains one of the more common complications. Thorough knowledge of vascular anomalies enables the surgeon to appropriately plan the operative strategy and minimize intraoperative complications. We present a case of a duplicated inferior vena cava diagnosed by computer tomography and our management of it during left sided LRN.

FULL TEXT

Case Report2015-02-25
10.5173/ceju.2010.04.art8
Primary Small Cell Carcinoma of The Bladder: A Case Report and Review of the Literature
Ahmad Omar, Nerys Williams, Nancy Chisholm, Mohammed Diab, Altaf Khattak, Leigh Forsyth
Primary small cell carcinoma is an entity or a disease. Despite its agressive clinical course, there is no consensus on an optimal treatment approach. We hereby present a localized terminal stage small cell bladder carcinoma case along with the related literature. A man at 81 has admitted to the clinic with massive hematuria complain. In radiological examination, a tumoral mass at nearly cm diameter was observed in bladder. Tissue biopsy samples were taken via transurethral resection method. In histopathological examination, primary small cell carcinoma cells were found.

FULL TEXT

Case Report2010-08-23
10.5173/ceju.2010.04.art9
SQUAMOUS CELL CARCINOMA CAUSED BY NEGLECTED GIANT BLADDER DIVERTICULUM STONE: CASE REPORT
Hasan Kocoglu, Cabir Alan
The incidence of bladder diverticula is approximately 1.7% in children and 6% in adults. Bladder tumors arising inside of a diverticula are uncommon, with a reported incidence ranging from 0.8% to 10%. In literature a large number of cases dealing with squamos cell carcinoma caused by bladder diverticula. Until now, a case report depicting the coexistence of these pathologies (SCC, diverticula and diverticula stone) simultaneously in one case has not been reported yet. In our case neglected bladder diverticulum stones may cause SCC

FULL TEXT

Case Report2010-09-12
10.5173/ceju.2010.04.art10
HUMAN OS PENIS : A CASE REPORT
Ahmet Resit Ersay, Cabir Alan, Hasan Kocoglu
This report presents a case of a 5-year-old male suffering from a rod-like mass at the base of penis. He was aware of its existence since pubertal ages. Physical examination revealed a bone hard, mobile, stick- like structure behind the corpus spongiosum, at median plane. A calcified periurethral rod-like 5cm. Mass at the ventral aspect of intercorporeal septum of penis was noted on CT scan. The patient who had no symptoms associated with erectile dysfunction refused further diagnostic tests and intervention.

FULL TEXT

"Central European Journal of Urology" is growing

Dear Friends, Colleagues,
Readers and Editors,

The importance of the "Central European Journal of Urology" is steadily increasing. This is of course,in a large part thanks to you. According to the SCOPUS database ranking of 98 urological journals published and indexed worldwide, our journal is ranked at the 58 th position. This is a very acceptable rank! First place is of course reserved by the "European Urology", but journals ranked near us show that our position is meaningful and the influence of the articles published in our journal is noticeable among the newest trending urological topics. This interesting SCOPUS ranking can be viewed on the following site: https://www.scopus.com/sourceid/19900192570?origin= sbrowse#tabs=1.

Independent of the Web of Science database, the citation index CiteScore prepared by SCOPUS, also contains positive news concerning our journal. In 2016, the CiteScore for the "Central European Journal of Urology" was 0.70. This index rating is calculated based on the amount of citations of articles published in a given journal during the last three years. By following the change in the citation index of the "Central European Journal of Urology", it can be easily seen that the importance of our journal is on the rise. The CiteScore in 2013 was 0.23, and increased to 0.37 and 0.62 in 2014 and 2015, respectively. What is the difference between the CiteScore (SCOPUS) from the Impact Factor (Web of Science)?

Both factors are derived from the amount of citations per published articles. It seems though that the CiteScore is more flexible. It is calculated more often (monthly), not yearly, as is the case for the Impact Factor. The method of calculation and assignment of the CiteScore is clear and available at all times to SCOPUS database users. Please follow how the CiteScore changes this year for the "Central European Journal of Urology"'. This information can be accessed by clicking on the CiteScoreTracker 2017tab. It is now that straight-forward!

By observing the changes occurring in international bibliographic databases, I think that thanks to these tools the SCOPUS database will soon become a very relevant player among the ranking systems and the CiteScore index will be of equal value to that developed by the Web of Science database. Perhaps overtime it will gain even more popularity?


Kindest regards,
Tomasz Drewa
Editor-in-Chief

Menu

About the journal

Subscription

Contact

Publications

Ahead of print

Current issue

Users

Submit manuscript

Instructions for authors

CEJU Publication System

© Copyright by Polish Urological Association

Logo CEJU